Earnings History Data for Achilles Therapeutics (ACHL) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Achilles Therapeutics
Achilles Therapeutics plc is a clinical-stage biopharmaceutical company. It engages in developing precision T cell therapies to treat solid tumors. Achilles Therapeutics plc is based in LONDON.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | ACHL | Achilles Therapeutics | 42.00 | -0.48 | -0.41 | 0.00 | Achilles Therapeutics GAAP EPS of -$0.48 [11/14/2024 7:29 AM] |
1.06 | 0.04 (4.24%) |
1.06 | 0.04 (3.92%) |
0.63 - 1.76 | 783,570 | 90,000 | 174,011 | ||
| 14-08-2024 | PM | ACHL | Achilles Therapeutics | 32.00 | -0.41 | -0.41 | 0.00 | Achilles Therapeutics GAAP EPS of -$0.41 [8/14/2024 12:09 PM] |
0.7870 | 0.01 (1.73%) |
0.79 | 0.01 (1.47%) |
0.74 - 1.76 | 11,066 | 40,000 | 850 | ||
| 04-04-2024 | PM | ACHL | Achilles Therapeutics | 49.00 | -0.46 | -0.15 | 0.00 | Achilles Therapeutics GAAP EPS of -$0.46 misses by $0.32 [4/4/2024 12:31 PM] |
0.8999 | -0.30 (-25.01%) |
0.99 | -0.21 (-17.52%) |
0.74 - 1.76 | 1,731,335 | 230,000 | 518,788 | ||
| 04-08-2023 | PM | ACHL | Achilles Therapeutics | 40.00 | -0.42 | -0.40 | 0.00 | Achilles Therapeutics GAAP EPS of -$0.42 misses by $0.02 [8/4/2023 1:33 PM] |
0.9950 | 0.0 (0.00%) |
1.00 | 0.0 (0.40%) |
0.75 - 3.45 | 40,424 | 90,000 | 500 | ||